Actively Recruiting
Natural History and Structural Consequences of a Diseased Bruch's Membrane in Pseudoxanthoma Elasticum (PXE)
Led by University Hospital, Bonn · Updated on 2025-07-02
100
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are conducting a monocentric observational study at the University Eye Hospital Bonn to explore the natural history and structural effects of a diseased Bruch's membrane (BrM) in people with Pseudoxanthoma Elasticum (PXE). The study aims to analyze BrM changes, choriocapillaris blood flow deficits, progression of retinal atrophy, and how different ABCC6 gene mutations relate to disease features and severity. The goal is to provide insights that could guide personalized treatments and improve patient counseling. The study will include 100 genetically confirmed PXE patients and 100 healthy controls. Participants will undergo non-invasive imaging methods such as high-resolution optical coherence tomography (OCT), OCT angiography, fundus photography, and infrared reflectance imaging. Blood samples will also be collected. Data will be gathered over a 10-year period, with specific attention to changes observed over two years, including the size of 'Peau d'orange', BrM alterations, choriocapillaris flow voids, and angioid streak length. Participants will be asked to hold still during imaging sessions to ensure accurate data capture. The study involves regular monitoring of eye structures and blood flow, as well as genetic analysis. Researchers will measure disease progression through various imaging outcomes and gene mutation correlations. Although no direct benefit is expected for participants, the findings may help shape future clinical trials and improve care for PXE patients.
CONDITIONS
Brief Title
Progression Assessment of PXE-associated Alterations
Who Can Participate
Eligibility Criteria
You may qualify if you...
- PXE diagnosis based on Plomp et al. criteria
- Clear ocular media
- Ability to hold head still for image acquisition
You will not qualify if you...
- Any eye disease not related to PXE
- Systemic diseases that prevent study examinations
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 2 years
Participants undergo imaging and examination to assess the structure of Bruch's Membrane and related ocular features.
Periodic imaging visits over 2 years
Duration - 2 years
Participants are monitored over time to evaluate progression of PXE-associated alterations in ocular structures.
Follow-up visits for imaging and assessments over 2 years
Trial Site Locations
Total: 1 location
1
Department of Ophthalmology, University Hospital Bonn, Germany
Bonn, North Rhine-Westphalia, Germany, 53125
Actively Recruiting
Research Team
K
Kristina Pfau, MD, FEBO
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here